Administration of rA1M, prior to the 177 Lu-DOTATATE administration, had an increasing trend of preserving reticulocyte population with increases in dose compared to the vehicle ( Figure 3 B), although this was not statistically significant.
← all excerpts
Recombinant α<sub>1</sub>-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a <sup>177</sup>Lu-DOTATATE Mouse Radiation Model.
2
—
—
The sentences
Administration of rA1M showed a clear trend towards reduced proteinuria (i.e., albumin/creatinine ratio) with all concentrations of rA1M, with 2 × 5 mg/kg resulting in a significant reduction ( Figure 3 A).